PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,721 | -44.4% | 14,133 | +0.8% | 0.00% | -50.0% |
| Q2 2023 | $569,950 | -12.1% | 14,014 | +4.7% | 0.00% | 0.0% |
| Q1 2023 | $648,369 | +13.4% | 13,385 | -10.7% | 0.00% | 0.0% |
| Q4 2022 | $571,939 | -17.2% | 14,984 | +8.9% | 0.00% | -33.3% |
| Q3 2022 | $691,000 | +28.2% | 13,763 | +2.3% | 0.00% | +50.0% |
| Q2 2022 | $539,000 | -29.3% | 13,449 | -34.1% | 0.00% | 0.0% |
| Q1 2022 | $762,000 | -23.9% | 20,408 | -18.8% | 0.00% | 0.0% |
| Q4 2021 | $1,001,000 | +12.1% | 25,129 | +4.8% | 0.00% | -33.3% |
| Q3 2021 | $893,000 | -31.1% | 23,989 | -21.8% | 0.00% | -25.0% |
| Q2 2021 | $1,297,000 | +4.4% | 30,678 | +16.9% | 0.00% | 0.0% |
| Q1 2021 | $1,242,000 | -16.0% | 26,238 | +8.3% | 0.00% | -20.0% |
| Q4 2020 | $1,478,000 | +71.1% | 24,218 | +31.0% | 0.01% | +25.0% |
| Q3 2020 | $864,000 | -7.7% | 18,487 | +0.2% | 0.00% | -20.0% |
| Q2 2020 | $936,000 | +74.3% | 18,446 | +53.3% | 0.01% | +25.0% |
| Q1 2020 | $537,000 | -48.0% | 12,033 | -44.1% | 0.00% | -20.0% |
| Q4 2019 | $1,033,000 | +35.9% | 21,517 | -4.3% | 0.01% | +25.0% |
| Q3 2019 | $760,000 | -25.0% | 22,475 | -0.2% | 0.00% | -33.3% |
| Q2 2019 | $1,013,000 | +7.3% | 22,511 | -10.2% | 0.01% | 0.0% |
| Q1 2019 | $944,000 | +25.9% | 25,067 | +14.7% | 0.01% | +20.0% |
| Q4 2018 | $750,000 | -38.7% | 21,854 | -16.1% | 0.01% | -37.5% |
| Q3 2018 | $1,224,000 | +42.3% | 26,034 | +2.2% | 0.01% | +33.3% |
| Q2 2018 | $860,000 | +30.7% | 25,484 | +4.8% | 0.01% | +50.0% |
| Q1 2018 | $658,000 | +39.4% | 24,307 | -14.1% | 0.00% | +33.3% |
| Q4 2017 | $472,000 | -9.6% | 28,306 | +8.6% | 0.00% | -40.0% |
| Q3 2017 | $522,000 | +18.1% | 26,069 | +8.1% | 0.01% | +25.0% |
| Q2 2017 | $442,000 | +102.8% | 24,115 | +8.9% | 0.00% | +100.0% |
| Q1 2017 | $218,000 | -28.8% | 22,145 | -21.0% | 0.00% | -33.3% |
| Q4 2016 | $306,000 | -12.3% | 28,015 | +12.6% | 0.00% | -40.0% |
| Q3 2016 | $349,000 | +67.8% | 24,886 | -15.8% | 0.01% | +66.7% |
| Q2 2016 | $208,000 | +10.1% | 29,573 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $189,000 | -82.1% | 29,330 | -9.7% | 0.00% | -76.9% |
| Q4 2015 | $1,053,000 | +34.3% | 32,490 | +10.6% | 0.01% | +18.2% |
| Q3 2015 | $784,000 | -48.0% | 29,368 | -6.2% | 0.01% | -47.6% |
| Q2 2015 | $1,507,000 | -22.1% | 31,317 | -1.5% | 0.02% | -8.7% |
| Q1 2015 | $1,934,000 | +35.9% | 31,791 | +15.7% | 0.02% | +35.3% |
| Q4 2014 | $1,423,000 | +33.0% | 27,487 | +13.1% | 0.02% | +21.4% |
| Q3 2014 | $1,070,000 | +40.8% | 24,304 | -16.4% | 0.01% | +40.0% |
| Q2 2014 | $760,000 | -14.4% | 29,063 | -14.5% | 0.01% | -9.1% |
| Q1 2014 | $888,000 | +348.5% | 33,988 | +191.9% | 0.01% | +266.7% |
| Q4 2013 | $198,000 | – | 11,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |